Ma Wei-Guo, Zhu Jun-Ming, Chen Yu, Qiao Zhi-Yu, Ge Yi-Peng, Li Cheng-Nan, Zheng Jun, Liu Yong-Min, Sun Li-Zhong
Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Diseases, Capital Medical University, Beijing, China.
Eur J Cardiothorac Surg. 2020 Aug 1;58(2):294-301. doi: 10.1093/ejcts/ezaa048.
Pregnancy-related aortic dissection (AoD) in Marfan syndrome is a lethal catastrophe. Due to its rarity and limited clinical experience, there is no consensus regarding the optimal management strategy. We seek to present our 21-year experience in such patients , focusing on management strategies and early and late outcomes.
Between 1998 and 2019, we managed 30 pregnant women with Marfan syndrome (mean age 30.7 ± 4.3 years) who sustained AoD at a mean of 28.3 ± 8.8 weeks of gestation (GWs). AoD was acute in 21 (70%), type A (TAAD) in 24 (80%) and type B (TBAD) in 6 (20%). Fourteen TAADs (58.3%, 14/24) and 2 TBADs (33.3%, 2/6) occurred in the third trimester or postpartum. The maximal aortic size was < 45 mm in 26.7% (8/30; 3 TAADs, 5 TBADs). Management strategy was based on the types of dissection and GWs (i.e. surgical versus medical treatment, surgery or delivery first).
TAADs were treated medically in 1 and surgically in 23. The timing of delivery and surgery were caesarean first at 35.4 ± 6.1 GWs in 7 (29.2%), followed by surgery after mean 46 days; single-stage C-section and surgery at 32.0 ± 5.0 GWs in 10 (41.7%); and surgery first at 18.0 ± 5.8 GWs in 6 (25%), followed by C-section after 20 days. Maternal and foetal mortality were 28.6% (2/7) and 14.3% (1/7), 10.0% (1/10) and 20.0% (2/10) and 16.7% (1/6) and 83.3% (5/6), respectively. Five TBADs (83.3%) were managed with C-section followed by surgery in 2 and medical treatment in 3. The respective maternal and foetal mortality were 50% (1/2) and 100% (2/2) and 33.3% (1/3) and 33.3% (1/3), respectively. One TBAD was managed surgically first followed by C-section, resulting in maternal survival and foetal death. Follow-up was complete in 95.8% (23/24) at 3.7 ± 2.9 years. Four late deaths occurred and reoperation was performed in 1 patient. Maternal and foetal survival were 64.3% and 54.1% at 6 years, respectively.
Management of AoD in pregnant women with Marfan syndrome should be based on types of dissection (surgical versus medical) and gestational age (delivery or surgery first), which largely determine maternal and foetal survival. Aortic repair should be considered prior to conception in women with Marfan syndrome even at diameters smaller than recommended by current guidelines.
马凡综合征患者妊娠相关主动脉夹层(AoD)是一种致命的灾难。由于其罕见性及临床经验有限,关于最佳治疗策略尚无共识。我们旨在介绍我们在这类患者中的21年经验,重点关注治疗策略及早期和晚期结局。
1998年至2019年期间,我们管理了30例马凡综合征孕妇(平均年龄30.7±4.3岁),她们在平均妊娠28.3±8.8周(GWs)时发生AoD。21例(70%)为急性AoD,24例(80%)为A型(TAAD),6例(20%)为B型(TBAD)。14例TAAD(58.3%,14/24)和2例TBAD(33.3%,2/6)发生在妊娠晚期或产后。最大主动脉直径<45mm的占26.7%(8/30;3例TAAD,5例TBAD)。治疗策略基于夹层类型和GWs(即手术与药物治疗、先手术还是先分娩)。
1例TAAD接受药物治疗,23例接受手术治疗。分娩和手术时机为:7例(29.2%)在35.4±6.1GWs时先剖宫产,平均46天后手术;1例(41.7%)在32.0±5.0GWs时行一期剖宫产和手术;6例(25%)在18.0±5.8GWs时先手术,20天后剖宫产。孕产妇和胎儿死亡率分别为28.6%(2/7)和14.3%(1/7)、10.0%(1/10)和20.0%(2/10)、16.7%(1/6)和83.3%(5/6)。5例TBAD(83.3%)先剖宫产,2例随后手术,3例接受药物治疗。孕产妇和胎儿死亡率分别为50%(1/2)和100%(2/2)、33.3%(1/3)和33.3%(1/3)。1例TBAD先手术,随后剖宫产,导致孕产妇存活、胎儿死亡。95.8%(23/24)的患者在3.7±2.9年时完成随访。发生4例晚期死亡,1例患者再次手术。6年时孕产妇和胎儿生存率分别为64.3%和54.1%。
马凡综合征孕妇AoD的治疗应基于夹层类型(手术与药物)和孕周(先分娩还是先手术),这在很大程度上决定了孕产妇和胎儿的生存。即使主动脉直径小于当前指南推荐值,马凡综合征女性在受孕前也应考虑进行主动脉修复。